Literature DB >> 15177004

Severe malignant osteopetrosis caused by a GL gene mutation.

Paola Quarello1, Marco Forni, Laura Barberis, Claudio Defilippi, M Francesca Campagnoli, Leandra Silvestro, Annalisa Frattini, Nader Chalhoub, Jean Vacher, Ugo Ramenghi.   

Abstract

Infantile malignant autosomal recessive osteopetrosis is a genetically heterogeneous disease caused by the inability of OCLs to resorb and remodel bone, resulting in generalized osteosclerosis and obliteration of marrow spaces and cranial foramina. The classical clinical features are pathological fractures, visual impairment, and bone marrow failure. Two human genes have been described as the cause of this form of osteopetrosis: the T-cell immune-regulator-1 (TCIRG1) gene, which is mutated in >50% of the patients, and the chloride channel 7 (ClCN7) gene, which accounts for approximately 10% of cases. We report the clinical, radiographic, and histopathologic findings of the first human osteopetrosis case caused by a mutation in the grey-lethal (GL) gene. The patient, a 9-day-old male infant, presented with a very severe osteopetrotic phenotype including substantial hepatosplenomegaly since birth, cytopenia, and progressive major liver failure. Skeletal radiographs revealed a generalized increase in bone density with loss of corticomedullary differentiation. Histopathologic bone examination showed the typical osteopetrotic changes, with absence of resorptive activity, and osteoclasts, slightly decreased in number, with evident morphological alterations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177004     DOI: 10.1359/JBMR.040407

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Role of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking.

Authors:  Subramanya N M Pandruvada; Janie Beauregard; Suzanne Benjannet; Monica Pata; Claude Lazure; Nabil G Seidah; Jean Vacher
Journal:  Mol Cell Biol       Date:  2015-11-23       Impact factor: 4.272

2.  Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency.

Authors:  Céline Héraud; Adam Griffiths; Subramanya N M Pandruvada; Manfred W Kilimann; Monica Pata; Jean Vacher
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

3.  Endoscopic third ventriculostomy for the treatment of osteopetrosis-related hydrocephalus: a case-based update.

Authors:  Bhoresh Dhamija; Benedetta Ludovica Pettorini; Guirish Solanki
Journal:  Childs Nerv Syst       Date:  2011-05-07       Impact factor: 1.475

4.  Effect of zoledronate on oral wound healing in rats.

Authors:  Junro Yamashita; Kiyono Koi; Dong-Ye Yang; Laurie K McCauley
Journal:  Clin Cancer Res       Date:  2010-12-13       Impact factor: 12.531

5.  Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axis.

Authors:  Bongjin Shin; Jungeun Yu; Eui-Soon Park; Seunga Choi; Jiyeon Yu; Jung Me Hwang; Hyeongseok Yun; Young-Ho Chung; Kwan Soo Hong; Jong-Soon Choi; Masamichi Takami; Jaerang Rho
Journal:  J Biol Chem       Date:  2014-10-30       Impact factor: 5.157

Review 6.  Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression?

Authors:  Morten A Karsdal; Per Qvist; Claus Christiansen; László B Tankó
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

8.  OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling.

Authors:  Michael E Feigin; Craig C Malbon
Journal:  Cell Signal       Date:  2008-01-24       Impact factor: 4.315

9.  Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis.

Authors:  Alessandro Prinetti; Federica Rocchetta; Elvira Costantino; Annalisa Frattini; Elena Caldana; Francesca Rucci; Arianna Bettiga; Pietro L Poliani; Vanna Chigorno; Sandro Sonnino
Journal:  Glycoconj J       Date:  2008-09-10       Impact factor: 2.916

10.  OSTM1 bone defect reveals an intercellular hematopoietic crosstalk.

Authors:  Monica Pata; Céline Héraud; Jean Vacher
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.